Project measures / variables set:   CSNA03   dist_l60_cocaine_in

ID, description, units MPD:90385   dist_l60_cocaine_in   distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]  
cocaine study
Measures • day:    • 1 (saline)    • 2 (saline)    • 3    • 5    • 7    • 9    • 11    • 12 (saline)    • 19
Data set, strains CSNA03   inbred w/CC8   10 strains     sex: both     age: 8-14wks
Procedure open field test
Comparisontimecourse, same cohort
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

CSNA03 - distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary          "within" = Within error     "between" = Between Error (Animal ID)

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
within   day 8 31117176322.0124 3889647040.2516 66.568 < 0.0001
within   day:sex 8 475005880.4098 59375735.0512 1.0162 0.422
within   day:strain 64 18055878943.7861 282123108.4967 4.8283 < 0.0001
within   day:sex:strain 64 4336556995.9977 67758703.0625 1.1596 0.191
within   Residuals 792 46277464478.5246 58431142.0183
between   sex 1 1668985584.4053 1668985584.4053 4.6251 0.0339
between   strain 8 151017964958.2722 18877245619.784 52.3126 < 0.0001
between   sex:strain 8 6824924057.0985 853115507.1373 2.3642 0.0226
between   Residuals 99 35724626655.5701 360854814.7027

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
CSNA03 90385 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 1 (saline)  dist_l60_cocaine_in_d1 inbred w/CC8 10 both 8-14wks
CSNA03 90391 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 2 (saline)  dist_l60_cocaine_in_d2 inbred w/CC8 10 both 8-14wks
CSNA03 90397 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 3  dist_l60_cocaine_in_d3 inbred w/CC8 10 both 8-14wks
CSNA03 90403 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 5  dist_l60_cocaine_in_d5 inbred w/CC8 10 both 8-14wks
CSNA03 90409 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 7  dist_l60_cocaine_in_d7 inbred w/CC8 10 both 8-14wks
CSNA03 90415 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 9  dist_l60_cocaine_in_d9 inbred w/CC8 10 both 8-14wks
CSNA03 90421 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 11  dist_l60_cocaine_in_d11 inbred w/CC8 10 both 8-14wks
CSNA03 90427 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 12 (saline)  dist_l60_cocaine_in_d12 inbred w/CC8 10 both 8-14wks
CSNA03 90433 open field test cocaine distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders   [cm]   day 19  dist_l60_cocaine_in_d19 inbred w/CC8 10 both 8-14wks